A Study On Kalladaippu(Urolithiasis) With Aanai Nerunjil Kudineer

A PROSPECTIVE OPEN LABELLED,NON RANDOMIZED,PHASE II,CLINICAL TRIAL OF"AANAI NERUNJIL KUDINEER"IN THE TREATMENT OF KALLADAIPPU NOI(UROLITHIASIS)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/040201

Enrollment

Registered

2022-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: AANAI NERUNJIL KUDINEER: To be administered 40ml orally twice daily after food for 45days Control Intervention1: Nil: Nil Control Intervention2: Nil: Nil Control Intervention3: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Patient with the symptoms of Renal colicky pain Loin to groin pain Nausea Vomiting and sweating Hematuria Oliguria Dysuria

Exclusion criteria

Exclusion criteria: Chronic appendicitis Cholecystitis Pyelonephritis Pelvic inflammatory disease Chronic renal failure Bilateral obstructive uropathy

Design outcomes

Primary

Measure	Time frame
Reduction in severity of Renal colicky pain, Reduction of Nausea/vomiting Reduction of Hematuria, Polyuria, Dysuria and Oliguria. The kidney stone is expelled to come out as such or be disintegrated and mixed with urine will be ensured. Timepoint: 45days	—

Secondary

Measure	Time frame
The secondary outcome is reduction in size of the kidney stone in USG abdomen and pelvis. Timepoint: 45days	—

Countries

India

Contacts

Public ContactDr JUSTUS ANTONY MDS PhD

Government Siddha Medical College & Hospital, Palayamkottai.

justusantony71@gmail.com9443090849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026